STEGLUJAN 15 mg/1

Steglujan 15 mg/1 combines ertugliflozin and sitagliptin for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

Steglujan 15 mg/1 is primarily used for type 2 diabetes management. It works by enhancing insulin sensitivity and reducing glucose absorption in the kidneys. People often ask, 'What is Steglujan used for?'—it's designed to help regulate blood sugar levels when diet and exercise alone are insufficient.

Common effects of Steglujan 15 mg/1 may include urinary tract infections, hypoglycemia, and digestive issues. Some users report increased urination or mild dizziness. Individual responses can vary, so monitoring is advised.

Handle Steglujan 15 mg/1 with care, especially if you have kidney or liver conditions. Avoid dehydration and monitor blood sugar levels regularly. Consult a healthcare provider before starting this medication.

Steglujan 15 mg/1 may interact with insulin, other diabetes medications, and certain antibiotics. Alcohol can exacerbate side effects, so moderation is recommended. Always inform your healthcare provider about all medications you're taking.